日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SlitNET: A Deep Learning Enabled Spectrometer Slit

SlitNET:一种基于深度学习的光谱仪狭缝

Zhang, Youxi; Bench, Ciaran; Surendranathan, Preveen; Bergholt, Mads S

Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2

对 SARS-CoV-2 木瓜蛋白酶样蛋白酶进行强效和选择性共价抑制

Brian C Sanders #, Suman Pokhrel #, Audrey D Labbe, Irimpan I Mathews, Connor J Cooper, Russell B Davidson, Gwyndalyn Phillips, Kevin L Weiss, Qiu Zhang, Hugh O'Neill, Manat Kaur, Jurgen G Schmidt, Walter Reichard, Surekha Surendranathan, Jyothi Parvathareddy, Lexi Phillips, Christopher Rainville, D

Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease

SARS-CoV-2主蛋白酶的共价narlaprevir和boceprevir衍生的杂合抑制剂

Kneller, Daniel W; Li, Hui; Phillips, Gwyndalyn; Weiss, Kevin L; Zhang, Qiu; Arnould, Mark A; Jonsson, Colleen B; Surendranathan, Surekha; Parvathareddy, Jyothi; Blakeley, Matthew P; Coates, Leighton; Louis, John M; Bonnesen, Peter V; Kovalevsky, Andrey

Potent and Selective Covalent Inhibition of the Papain-like Protease from SARS-CoV-2

对 SARS-CoV-2 木瓜蛋白酶样蛋白酶进行强效和选择性共价抑制

Brian Sanders, Suman Pokhrel, Audrey Labbe, Irimpan Mathews, Connor Cooper, Russell Davidson, Gwyndalyn Phillips, Kevin Weiss, Qiu Zhang, Hugh O'Neill, Manat Kaur, Lori Ferrins, Jurgen Schmidt, Walter Reichard, Surekha Surendranathan, Jyothi Parvathareddy, Lexi Phillips, Christopher Rainville, David

Potent and Selective Covalent Inhibition of the Papain-like Protease from SARS-CoV-2

对SARS-CoV-2木瓜蛋白酶样蛋白酶的强效选择性共价抑制

Sanders, Brian; Pokhrel, Suman; Labbe, Audrey; Mathews, Irimpan; Cooper, Connor; Davidson, Russell; Phillips, Gwyndalyn; Weiss, Kevin; Zhang, Qiu; O'Neill, Hugh; Kaur, Manat; Ferrins, Lori; Schmidt, Jurgen; Reichard, Walter; Surendranathan, Surekha; Parvathareddy, Jyothi; Phillips, Lexi; Rainville, Christopher; Sterner, David; Kumaran, Desigan; Andi, Babak; Babnigg, Gyorgy; Moriarty, Nigel; Adams, Paul; Joachimiak, Andrzej; Hurst, Brett; Kumar, Suresh; Butt, Tauseef; Jonsson, Colleen; Wakatsuki, Soichi; Galanie, Stephanie; Head, Martha; Parks, Jerry

A Real-World Data Study on the Healthcare Resource Use for Uncontrolled Moderate-to-Severe Atopic Dermatitis in Secondary Care in the United Kingdom Prior to the Introduction of Biologic Treatment

一项基于真实世界数据的研究,探讨了生物制剂治疗引入前,英国二级医疗机构中未控制的中重度特应性皮炎患者的医疗资源利用情况。

Hudson, Richard D A; Ameen, Mahreen; George, Susannah M C; Harwood, Catherine A; Weller, Richard B; Lear, John T; Rout, Rajesh; Surendranathan, Thishi; Petrovic, Milos; Bewley, Anthony P

Introduction of an assessment toolkit associated with increased rate of DLB diagnosis

引入与路易体痴呆症诊断率提高相关的评估工具包

Surendranathan, A; Kane, J; Bentley, A; Barker, S; McNally, R; Bamford, C; Taylor, J-P; Thomas, A; McKeith, I; Burn, D; O'Brien, J T

Drug Repurposing to Identify Nilotinib as a Potential SARS-CoV-2 Main Protease Inhibitor: Insights from a Computational and In Vitro Study

药物再利用:尼洛替尼作为潜在的SARS-CoV-2主蛋白酶抑制剂的发现:一项计算和体外研究的启示

Banerjee, Souvik; Yadav, Shalini; Banerjee, Sourav; Fakayode, Sayo O; Parvathareddy, Jyothi; Reichard, Walter; Surendranathan, Surekha; Mahmud, Foyez; Whatcott, Ryan; Thammathong, Joshua; Meibohm, Bernd; Miller, Duane D; Jonsson, Colleen B; Dubey, Kshatresh Dutta

Development of Murine Leukemia Virus Integrase-Derived Peptides That Bind Brd4 Extra-Terminal Domain as Candidates for Suppression of Acute Myeloid Leukemia

开发与 Brd4 额外末端结构域结合的鼠白血病病毒整合酶衍生肽作为抑制急性髓系白血病的候选药物

Enming Xing, Nandini Surendranathan, Xiaotian Kong, Natalie Cyberski, Jessica D Garcia, Xiaolin Cheng, Amit Sharma, Pui-Kai Li, Ross C Larue

[(18)F]-AV-1451 binding in the substantia nigra as a marker of neuromelanin in Lewy body diseases

[(18)F]-AV-1451 在黑质中的结合作为路易体病中神经黑色素的标志物

Mak, Elijah; Kouli, Antonina; Holland, Negin; Nicastro, Nicolas; Savulich, George; Surendranathan, Ajenthan; Malpetti, Maura; Manavaki, Roido; Hong, Young T; Fryer, Tim D; Aigbirhio, Franklin; Rowe, James B; O'Brien, John T; Williams-Gray, Caroline H